Haematologic Neoplasms
Oncology·MeSH: Hereditary Sensory and Autonomic Neuropathies
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| AZD2962 | ASTRAZENECA PLC (AZN) |
Frequently asked questions
How many drugs are in development for Haematologic Neoplasms?
BioSniper tracks 1 drug in development for Haematologic Neoplasms across 1 company.
How many clinical trials target Haematologic Neoplasms?
There are 1 clinical trial targeting Haematologic Neoplasms tracked by BioSniper.
Deep-dive into Haematologic Neoplasms
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis